To evaluate the clinical effect of simotang for gastrointestinal dysfunction with no gastrointestinal surgery. We searched CNKI

VIP

wanfang (1989—2011) to identify randomized controlled trials about simotang for gastrointestinal dysfunction patients with no gastrointestinal surgery. The methodological quality was assessed and the data was obtained according to the Cochrane Reviewer’s Handbook and related methods.Meta-analyses were performed using Rev Man 4.2.7 softwar.Forty-four eligible studies were included.The results of meta-analyses showed that simotang could shorten the anus exhaust time than the control group ;Simotang can reduce the incidence of abdominal distension ;Simotang can improve the adequacy of lactation than the control group .Find no adverse reaction. Comparied with the control group

simotang can improve the therapeutic effect on the patients whose gastrointestinal dysfunction with no gastrointestinal surgery and have high security. But because the literatures exist a low quality and partial

its curative effect still needs the strict

randomized

double-blind tests to be confirmed.